← Back to all trials
Enrolling By Invitation
NCT05764642
A Study of Renal Microvessel Imaging for Chronic Kidney Disease
Conditions: Healthy, Chronic Kidney Diseases
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: Yes
Phase: PHASE2
Enrollment: 186
Sponsor: Mayo Clinic
Location: Mayo Clinic Florida Jacksonville Florida
Summary
The purpose of this research is to study the efficacy of ultrasound microvessel imaging for evaluation of Chronic Kidney Disease. Definity is an ultrasound contrast agent currently approved by the FDA for use on the heart, liver, and urinary tract. This study will look at its effectiveness on the kidney.
Eligibility Criteria
Inclusion Criteria:
\- Healthy volunteers or Chronic Kidney Disease (CKD) patients with clinically indicated renal biopsy.
Exclusion Criteria:
* Subjects lacking capacity to consent.
* Vulnerable subjects such as prisoners; pregnant women; nursing mother.
* Subjects with history of hypersensitivity allergic reactions to ultrasound contrast agents.
* Patients with high-risk cardiac diseases.
Source: ClinicalTrials.gov (NCT05764642). StuddyBuddy aggregates publicly available trial information.
